Product Information
DEXAMETHASONE 0.5 MG/5 ML LIQ is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1718 per ML under NDC 00054317757. Its NADAC has been published 467 times since Nov 28, 2013.
FDA first approved this application on Sep 1, 1983.
Strength
.5 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054317757
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONEApproval Type
Generic (ANDA)
FDA Application
ANDA088248FDA Approved
9/1/1983
On Market Since
9/1/1983
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 0.5 MG/5 ML LIQ has been published 467 times since Nov 28, 2013, and over the history we have for it it has declined 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1718 per ML |
|---|---|
| All-time high | $0.2058 (Mar 11, 2015) |
| All-time low | $0.1024 (May 22, 2024) |
| 52-week high | $0.1718 |
| 52-week low | $0.1467 |
| Median price | $0.1701 |
| Average price | $0.1691 |
| Largest weekly change | -24.0% (Apr 17, 2024) |
| Weeks tracked | 467 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexamethasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 0.5 MG/5 ML LIQ?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 0.5 MG/5 ML LIQ, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1718 per ML (NDC 00054317757), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 0.5 MG/5 ML LIQ changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 0.5 MG/5 ML LIQ has declined 2.2%. It has been tracked across 467 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 0.5 MG/5 ML LIQ?
Since Nov 28, 2013, the NADAC for DEXAMETHASONE 0.5 MG/5 ML LIQ has ranged from a low of $0.1024 (May 22, 2024) to a high of $0.2058 (Mar 11, 2015), with a median of $0.1701 per ML.
Are there cheaper alternatives to DEXAMETHASONE 0.5 MG/5 ML LIQ?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 0.5 MG/5 ML LIQ, is $0.0294 per ML — about 83% below DEXAMETHASONE 0.5 MG/5 ML LIQ.
Who manufactures DEXAMETHASONE 0.5 MG/5 ML LIQ?
DEXAMETHASONE 0.5 MG/5 ML LIQ (NDC 00054317757) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.